Coronary Stent Market Size, Share, Trends, Industry Analysis Report: By Type (Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioabsorbable Stents), Mode of Delivery, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Mi

The global coronary stent market size is expected to reach USD 25.78 billion by 2034, according to a new study by Polaris Market Research. The report “Coronary Stent Market Size, Share, Trends, Industry Analysis Report: By Type (Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioabsorbable Stents), Mode of Delivery, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The coronary stent market is experiencing significant growth driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and the rising demand for minimally invasive procedures. Key drivers include the need for effective treatments for coronary artery disease and the adoption of drug-eluting and bioresorbable stents, which improve patient outcomes by reducing restenosis rates.

Opportunities exist in emerging markets, where healthcare infrastructure improvements and rising awareness of cardiovascular health are boosting demand. Key coronary stent market trends, including the development of next-generation stents with enhanced safety features, increased focus on patient-centric solutions, and the integration of digital health technologies, are expected to shape the market trajectory. With continuous innovation and an expanding global patient base, the market is poised for continued growth in the coming years.

Coronary Stent Market Report Highlights

Based on type, the drug-eluting stents (DES) segment dominates the market due to their ability to reduce restenosis rates and improve long-term patient outcomes, with growing adoption driven by advancements in stent technology. Bioabsorbable stents are the fastest-growing segment, gaining traction due to their innovative design that reduces long-term complications.

By mode of delivery, balloon-expandable stents hold the largest market share, favored for their precision in deployment and effectiveness in treating coronary artery disease. The self-expanding stents segment is experiencing the fastest growth, particularly in complex cases with tortuous or calcified arteries due to their adaptability and flexibility.

In terms of end user, the hospitals segment dominates the market due to their comprehensive treatment capabilities and the high volume of coronary interventions performed. Cardiac centers are the fastest-growing segment, driven by their specialized focus on cardiovascular treatments and an increasing number of dedicated facilities.

North America holds the largest market share, supported by advanced healthcare infrastructure, high treatment adoption rates, and substantial investments in cardiovascular care. Asia Pacific is the fastest-growing region, fueled by increasing healthcare access, rising cardiovascular disease prevalence, and expanding medical infrastructure.

Notable companies include Abbott Laboratories; Medtronic; Boston Scientific Corporation; Terumo Corporation; B. Braun Melsungen AG; C. R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company); Cook Medical Inc.; Biotronik SE & Co. KG; MicroPort Scientific Corporation; Biosensors International Group, Ltd.; Stentys SA; Lepu Medical Technology (Beijing) Co., Ltd.; Meril Life Sciences Pvt. Ltd.; SMT (Sahajanand Medical Technologies); and REVA Medical, Inc.

Polaris Market Research has segmented the coronary stent market report on the basis of type, mode of delivery, end user, and region:

By Type Outlook (Revenue – USD Billion, 2020–2034)

Bare-Metal Stents (BMS)

Drug-Eluting Stents (DES)

Bioabsorbable Stents

By Mode of Delivery Outlook (Revenue – USD Billion, 2020–2034)

Balloon-Expandable Stents

Self-Expanding Stents

By End User Outlook (Revenue – USD Billion, 2020–2034)

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Others

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

• US
• Canada

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Mexico
• Brazil
• Argentina
• Rest of Latin America